Company Data
Lyell Immunopharma Inc.
Ticker
LYEL
Current Price
$23.84 6.86%
Market Cap
$505.8M
Price Target
Refer to Report
Volume
31.8K
52wk Range
$7.65 - $25.2
Overview
Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).